NextGen Healthcare (NXGN) Misses Q4 EPS by 1c; Offers FY22 Guidance

NextGen Healthcare (NASDAQ: NXGN) reported Q4 EPS of $0.19, $0.01 worse than the analyst estimate of $0.20. Revenue for the quarter came in at $151.3 million versus the consensus estimate of $148.17 million.

GUIDANCE:

NextGen Healthcare sees FY2023 EPS of $0.95-$1.01, versus the consensus of $0.98. NextGen Healthcare sees FY2023 revenue of $628-640 million, versus the consensus of $595 million.

For earnings history and earnings-related data on NextGen Healthcare (NXGN) click here.

You May Also Be Interested In

• FedEx (FDX) Misses Q4 EPS by 1c, Offers FY23 EPS Guidance Tops Consensus
• Apogee Enterprises (APOG) Tops Q1 EPS by 44c, Hikes FY23 EPS Guidance
• KB Home (KBH) Tops Q2 EPS by 32c, Offers Guidance